COVID-19 Vaccines - Botswana

Botswana

Highlights

Botswana is projected to generate a revenue of US$6.48m in the COVID-19 Vaccines market by 2024.
It is expected to witness an annual growth rate (CAGR 2024-2029) of -17.35%, reaching a market volume of US$2.50m by 2029.
In comparison to other countries, United States is anticipated to generate the highest revenue of US$4.39bn in 2024.
Botswana is experiencing a surge in demand for COVID-19 vaccines as the government implements a comprehensive vaccination campaign to protect its population.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

Botswana, like many other countries in Africa, has been affected by the COVID-19 pandemic. The country has seen a rise in COVID-19 cases, leading to an increase in demand for COVID-19 vaccines. In this market data analysis, we will explore the trends and developments in the COVID-19 Vaccines market in Botswana.

Customer preferences: The demand for COVID-19 vaccines in Botswana is high, with many people eager to get vaccinated. However, there is some hesitancy among the population, with some people being skeptical about the safety and efficacy of the vaccines. There is also a preference for certain vaccine brands, with some people preferring vaccines from certain manufacturers over others.

Trends in the market: The COVID-19 Vaccines market in Botswana is still in its early stages, with the government working to secure more doses of the vaccine. The country has received vaccines through the COVAX facility, a global initiative aimed at ensuring equitable access to COVID-19 vaccines. There is also a growing trend of private companies and organizations purchasing vaccines for their employees and members. This has led to concerns about equity and access to the vaccine, as those who can afford to purchase the vaccine may be prioritized over those who cannot.

Local special circumstances: Botswana has a relatively small population, which has made it easier to distribute vaccines to the population. The government has also implemented a phased approach to vaccine distribution, prioritizing healthcare workers and other high-risk individuals. However, there are still challenges in reaching remote and rural areas of the country, where access to healthcare services may be limited.

Underlying macroeconomic factors: Botswana's economy has been impacted by the COVID-19 pandemic, with a slowdown in economic activity and a decline in revenue from key sectors such as tourism and mining. The government has had to redirect resources towards the COVID-19 response, including vaccine procurement and distribution. This has put a strain on the country's finances, which were already under pressure due to the pandemic.In conclusion, the COVID-19 Vaccines market in Botswana is still developing, with the government working to secure more doses of the vaccine and private companies also purchasing vaccines for their employees. There is a high demand for the vaccine, but also some hesitancy and preference for certain vaccine brands. The country's small population has made it easier to distribute vaccines, but there are still challenges in reaching remote and rural areas. The pandemic has also had an impact on the country's economy, with resources being redirected towards the COVID-19 response.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.